1.
Ostrovskaya O, Sips M, Ulrichts P, Trainor L, Verheesen P, Stoykov I. Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s193. Available from: https://jofskin.org/index.php/skin/article/view/1950